What Is Raising Regulus Therapeutics (RGLS) Stock This Morning?

Regulus Therapeutics Inc. (RGLS) shares gained 15.69% to $1.92 in Monday’s early session after reporting positive clinical trial results. A recent 5-day performance of 24.44% has been achieved by RGLS stock, which gained 5.00% last trading session to finish at $1.68. RGLS has shared what data? Today, Regulus Therapeutics (RGLS) announced that its Phase 1 […]